WELLS FARGO ADVANTAGE SMALL COMPANY GROWTH FUND CLASS R6 (WSCRX US) stock market data APIs
35.3899
0(0%)
as of July 10, 2025
Try our APIs with
free plan!
WELLS FARGO ADVANTAGE SMALL COMPANY GROWTH FUND CLASS R6 Financial Data Overview
Price chart is built with
Anychart
Prev. Close
35.3899
Open
35.3899
High
35.3899
Low
35.3899
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get WELLS FARGO ADVANTAGE SMALL COMPANY GROWTH FUND CLASS R6 data using free add-ons & libraries
End-of-day & Earnings data
Get WELLS FARGO ADVANTAGE SMALL COMPANY GROWTH FUND CLASS R6 Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get WELLS FARGO ADVANTAGE SMALL COMPANY GROWTH FUND CLASS R6 End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
WELLS FARGO ADVANTAGE SMALL COMPANY GROWTH FUND CLASS R6 News
New
Poxel Announces Completion of Arbitration with Merck Serono
POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohe...
Poxel Announces Completion of Arbitration with Merck Serono
POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohe...
Poxel Reports Financial Update for Cash and Revenue for the Full Year 2020 and Provides Corporate Update
As of December 31, 2020, cash and cash equivalents were EUR 40.2 million (USD 49.4 million) New results from the PXL770 Phase 2a STAMP-NAFLD trial for the treatment of NASH showed consistently greate...
Poxel Reports Financial Update for Cash and Revenue for the Full Year 2020 and Provides Corporate Update
As of December 31, 2020, cash and cash equivalents were EUR 40.2 million (USD 49.4 million) New results from the PXL770 Phase 2a STAMP-NAFLD trial for the treatment of NASH showed consistently greate...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
